Alpa Laboratories Future Growth

Future criteria checks 0/6

We currently don't have sufficient analyst coverage to forecast growth and revenue for Alpa Laboratories.

Key information

n/a

Earnings growth rate

n/a

EPS growth rate

Pharmaceuticals earnings growth	18.7%
Revenue growth rate	n/a
Future return on equity	n/a
Analyst coverage	None
Last updated	n/a

Recent future growth updates

No updates

Recent updates

Here's Why We Think Alpa Laboratories (NSE:ALPA) Might Deserve Your Attention Today

Dec 14

Shareholders May Not Be So Generous With Alpa Laboratories Limited's (NSE:ALPA) CEO Compensation And Here's Why

Sep 23

If You Like EPS Growth Then Check Out Alpa Laboratories (NSE:ALPA) Before It's Too Late

Feb 23

Alpa Laboratories' (NSE:ALPA) Earnings Aren't As Good As They Appear

Nov 24

Here's Why I Think Alpa Laboratories (NSE:ALPA) Might Deserve Your Attention Today

Oct 05

Do Alpa Laboratories's (NSE:ALPA) Earnings Warrant Your Attention?

May 31

With EPS Growth And More, Alpa Laboratories (NSE:ALPA) Is Interesting

Jan 28

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Alpa Laboratories has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.

Earnings and Revenue Growth Forecasts

NSEI:ALPA - Analysts future estimates and past financials data (INR Millions)
Date	Revenue	Earnings	Free Cash Flow	Cash from Op	Avg. No. Analysts
12/31/2023	1,148	178	N/A	N/A	N/A
9/30/2023	1,148	185	354	373	N/A
6/30/2023	1,054	130	N/A	N/A	N/A
3/31/2023	930	126	78	89	N/A
12/31/2022	1,007	45	N/A	N/A	N/A
9/30/2022	1,022	48	-42	-34	N/A
6/30/2022	1,113	103	N/A	N/A	N/A
3/31/2022	1,123	141	77	99	N/A
12/31/2021	1,121	156	N/A	N/A	N/A
9/30/2021	1,159	139	-78	-37	N/A
6/30/2021	1,128	105	N/A	N/A	N/A
3/31/2021	976	72	-49	-17	N/A
12/31/2020	907	69	N/A	N/A	N/A
9/30/2020	817	58	N/A	N/A	N/A
6/30/2020	821	39	N/A	N/A	N/A
3/31/2020	860	19	152	178	N/A
12/31/2019	869	9	N/A	N/A	N/A
9/30/2019	888	6	N/A	N/A	N/A
6/30/2019	817	11	N/A	N/A	N/A
3/31/2019	780	10	-19	-10	N/A
3/31/2018	628	28	-147	-127	N/A
3/31/2017	635	25	N/A	170	N/A
3/31/2016	536	68	N/A	-219	N/A
3/31/2015	574	-14	N/A	-18	N/A
12/31/2014	618	-19	N/A	N/A	N/A
9/30/2014	627	-46	N/A	N/A	N/A
6/30/2014	573	-60	N/A	N/A	N/A
3/31/2014	567	-52	N/A	81	N/A
12/31/2013	566	-66	N/A	N/A	N/A
9/30/2013	539	-84	N/A	N/A	N/A
6/30/2013	523	-61	N/A	N/A	N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if ALPA's forecast earnings growth is above the savings rate (6.7%).

Earnings vs Market: Insufficient data to determine if ALPA's earnings are forecast to grow faster than the Indian market

High Growth Earnings: Insufficient data to determine if ALPA's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: Insufficient data to determine if ALPA's revenue is forecast to grow faster than the Indian market.

High Growth Revenue: Insufficient data to determine if ALPA's revenue is forecast to grow faster than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: Insufficient data to determine if ALPA's Return on Equity is forecast to be high in 3 years time

Alpa Laboratories Future Growth

Future criteria checks 0/6

Key information

Recent future growth updates

Recent updates

Third quarter 2024 earnings released: EPS: ₹2.17 (vs ₹2.43 in 3Q 2023)

Here's Why We Think Alpa Laboratories (NSE:ALPA) Might Deserve Your Attention Today

Investor sentiment improves as stock rises 17%

Alpa Laboratories Limited to Report Q2, 2024 Results on Nov 07, 2023

Shareholders May Not Be So Generous With Alpa Laboratories Limited's (NSE:ALPA) CEO Compensation And Here's Why

Alpa Laboratories Limited, Annual General Meeting, Sep 29, 2023

High number of new directors

Alpa Laboratories Limited Announces Directors Appointments

Here's Why Alpa Laboratories (NSE:ALPA) Has Caught The Eye Of Investors

Less than half of directors are independent

Investor sentiment improves as stock rises 16%

First quarter 2024 earnings released: EPS: ₹1.44 (vs ₹1.29 in 1Q 2023)

Full year 2023 earnings released: EPS: ₹5.90 (vs ₹6.70 in FY 2022)

Third quarter 2023 earnings released: EPS: ₹2.43 (vs ₹2.57 in 3Q 2022)

Is Alpa Laboratories (NSE:ALPA) A Risky Investment?

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Investor sentiment deteriorated over the past week

Is Now The Time To Put Alpa Laboratories (NSE:ALPA) On Your Watchlist?

Full year 2022 earnings released: EPS: ₹6.67 (vs ₹3.44 in FY 2021)

Investor sentiment deteriorated over the past week

Investor sentiment deteriorated over the past week

Insufficient new directors

Investor sentiment improved over the past week

If You Like EPS Growth Then Check Out Alpa Laboratories (NSE:ALPA) Before It's Too Late

Third quarter 2022 earnings: Revenues and EPS in line with analyst expectations

Alpa Laboratories Limited to Report Q3, 2022 Results on Feb 14, 2022

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Alpa Laboratories' (NSE:ALPA) Earnings Aren't As Good As They Appear

Here's Why I Think Alpa Laboratories (NSE:ALPA) Might Deserve Your Attention Today

Investor sentiment improved over the past week

Company Secretary & Compliance Officer Aditya Singh has left the company

Full year 2021 earnings released: EPS ₹3.45 (vs ₹0.88 in FY 2020)

Do Alpa Laboratories's (NSE:ALPA) Earnings Warrant Your Attention?

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Alpa Laboratories Limited Appoints Aditya Singh as Company Secretary Cum Compliance Officer

Third quarter 2021 earnings released: EPS ₹1.77 (vs ₹1.23 in 3Q 2020)

New 90-day high: ₹39.85

Alpa Laboratories Limited to Report Q3, 2021 Results on Feb 12, 2021

With EPS Growth And More, Alpa Laboratories (NSE:ALPA) Is Interesting

Alpa Laboratories Limited Announces Executive Changes

Market bids up stock over the past week

New 90-day high: ₹31.35

First quarter earnings released

New 90-day high - ₹31.20

Alpa Laboratories Limited to Report Q1, 2021 Results on Aug 25, 2020

Earnings and Revenue Growth Forecasts

Analyst Future Growth Forecasts

Earnings per Share Growth Forecasts

Future Return on Equity

Discover growth companies